Category: News & Articles
... (Keytruda) and nivolumab (Opdivo) are heralding this new era in cancer treatment. Some people taking these drugs can see their cancer completely disappear; there’s nothing left to see on their ... . Checkpoint immunotherapy has proven beneficial in patients with bladder cancer , head and neck cancer and Hodgkin lymphoma . A ...
Category: News & Articles
... into the common cold would lead to development of the anti-cancer therapy , CAVATAK®. “When I first started with this project, ... was focusing on a cure for a common cold and not at all looking into cancer. There were a few serendipitous events that led us down a ... America, Australia and the United Kingdom in lung cancer, metastatic bladder cancer and melanoma, with hopes that ongoing results will reveal ...
Category: News & Articles
... oncologist Associate Professor Jarad Martin, a member of HMRI’s Cancer Research Alliance, is using advanced MRI scanning to accurately ... can knock their ability to have erections, and varying degrees of bladder leakage is also common.” Associate Professor Martin is ... he said. “We obsess over fractions of a millimetre because the bladder and rectum are right next to the prostate.” A radical new form ...
Category: News & Articles
... the completion of international clinical trials for a targeted anti-cancer therapy known as CAVATAK™. Viralytics Limited, a biotech ... the completion of international clinical trials for a targeted anti-cancer therapy known as CAVATAK™. A Phase 2 trial is currently ... in patients with tumours including prostate, lung or metastatic bladder cancers. Viralytics announced it has binding commitments to ...
Category: Researcher Profiles
... patient outcomes? I undertake clinical, translational and basic cancer research in melanoma, brain, prostate, bladder and kidney cancers. Why did you get into research? My research ... is inspired by working for patients with melanoma, brain, prostate, bladder and kidney cancers. Dr Gedye’s research focuses on complexity ...
Category: Research
... conditions and also for the treatment of other diseases such as cancer. Several important molecules and genetic factors have already ... interest in harnessing the evasive properties of viruses for treating cancer. That is, using the ability of viruses to escape our immune ... viral therapy for the treatment of melanoma, metastatic disease and bladder cancer. A number of vaccines and specific vaccine formulations ...
Category: News & Articles
... Cavatak, a drug that uses the common cold virus to infect and kill cancer cells. Cavatak is currently being studied in multiple Phase I and ... biotechnology therapies. “The basic premise of Cavatak is to cause cancer cells to rupture and die, while also stimulating a wider immune ... Merck’s immunotherapy drug Keytruda on melanoma, prostate, lung and bladder cancers and we’re eager to see those results.” Dr Malcolm ...